Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Clinical Trial Investigating the Efficacy of Single-Dose Fosaprepitant for the Prevention of Cisplatin-Induced Nausea and Vomiting (CINV) in Patients With Head & Neck Cancer Undergoing Concurrent Chemotherapy and Radiation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00895245
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:33.704503+00:00
Published At
2017-05-18T00:00:00+00:00
Record Updated At
2017-05-18
Results Posted At
2017-05-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Nausea and Vomiting", "Stage III Squamous Cell Carcinoma of the Hypopharynx", "Stage III Squamous Cell Carcinoma of the Larynx", "Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity", "Stage III Squamous Cell Carcinoma of the Nasopharynx", "Stage III Squamous Cell Carcinoma of the Oropharynx", "Stage IV Squamous Cell Carcinoma of the Hypopharynx", "Stage IV Squamous Cell Carcinoma of the Larynx", "Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity", "Stage IV Squamous Cell Carcinoma of the Nasopharynx", "Stage IV Squamous Cell Carcinoma of the Oropharynx"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-05-18"
protocolSection.identificationModule.nctId
"NCT00895245"
protocolSection.identificationModule.officialTitle
"A Phase II Clinical Trial Investigating the Efficacy of Single-Dose Fosaprepitant for the Prevention of Cisplatin-Induced Nausea and Vomiting (CINV) in Patients With Head \u0026 Neck Cancer Undergoing Concurrent Chemotherapy and Radiation"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-05-18"

Study condition terms

  • Nausea and Vomiting (protocolSection.conditionsModule.conditions)
  • Stage III Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
  • Stage III Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage III Squamous Cell Carcinoma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Stage III Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Nasopharynx (protocolSection.conditionsModule.conditions)
  • Stage IV Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.